Andrea Stevens
Company: Janssen
Job title: Director, Precision Medicine Access Strategy
Seminars:
Addressing the Reimbursement Paradigm in Dx Testing to Maximise Access to Precision Medicines
Track Chair 10:55 am
day: Track B - Day 2 am
Chair’s Opening Remarks 8:20 am
day: Day Two Morning
Regulation Panel Discussion: Scaling a Biomarker Test to Global Markets 5:25 pm
• Discussing the nuances in regulatory approvals and launching drug & diagnostic products in different markets (US, EU, APAC) • The importance of China as a market and why industry should come together more to discuss streamlining infrastructure planning and data handling protection to lower costs and planning time when launching biomarker-driven drug programmesRead more
day: Track B - Day 1 pm